Two members of the Cryptococcus neoformans-gattii species complex, the etiologic agents of cryptococcosis, can be differentiated by biological, biochemical, serological and molecular typing techniques. Based on their differences in carbon and nitrogen utilization patterns, cost effective and very specific diagnostic tests using D-proline and canvanine-glycine-bromthymol blue (CGB) media have been formulated and are widely used for identification of the two species. However, these methods have yet to be tested for strains with confirmed molecular types to assess the degree of specificity for each molecular type in the two species. We collected global isolates of every major molecular type available and tested their patterns of nitrogen utilization. We confirmed specificity of the CGB test to be 100% regardless of molecular type while the D-proline test yielded 8–38% false negative results in three of the four C. gattii molecular types, VGI–VGIII. The utilization pattern of a new set of amino acids: D-alanine, L-tryptophan and L-phenylalanine, showed species specificity comparable to that of D-proline. We discovered that the transcription factor Gat1 (Are1) regulates the utilization of nitrogen differently between C. neoformans and C. gattii strains. Unlike in C. neoformans, expression of the genes encoding glycine decarboxylase complex in C. gatti was only partially suppressed by nitrogen catabolite repression in the presence of ammonium. GAT1 in C. neoformans controlled the induction of three of the four genes encoding the glycine decarboxylase complex when glycine was used as the sole nitrogen source while in C. gattii its regulation of these genes was less stringent. Moreover, while virulence of C. neoformans strains in mice was not affected by Gat1, the transcription factor positively influenced the virulence of C. gattii strain.
References
[1]
Heitman J, Kozel TR, Kwon-Chung J, Perfect JR, Casadevall A (2011) Cryptococcus: from human pathogen to model yeast. Washington, DC: ASM press. 620 p.
[2]
Kwon-Chung J, Boekhout T, Wickes B, Fell J (2011) Systematics of the Genus Cryptococcus and its type species C. neoformans. In: Heitman J, Kozel TR, Kwon-Chung J, Perfect JR, Casadevall A, editors. Cryptococcus: From human pathogen to model yeast. Washington, DC: ASM press. pp. 3–16.
[3]
Meyer W, Castaneda A, Jackson S, Huynh M, Castaneda E (2003) Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis 9: 189–195.
[4]
Boekhout T, Theelen B, Diaz M, Fell JW, Hop WC, et al. (2001) Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiology 147: 891–907.
[5]
Meyer W, Aanensen DM, Boekhout T, Cogliati M, Diaz MR, et al. (2009) Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol 1–14.
[6]
Bovers M, Hagen F, Boekhout T (2008) Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex. Rev Iberoam Micol 25: S4–12.
[7]
Ngamskulrungroj P, Gilgado F, Faganello J, Litvintseva AP, Leal AL, et al. (2009) Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties. PLoS One 4: e5862.
[8]
Bennett JE, Kwon-Chung KJ, Howard DH (1977) Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol 105: 582–586.
[9]
Franzot SP, Salkin IF, Casadevall A (1999) Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol 37: 838–840.
[10]
Levitz SM (1991) The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 13: 1163–1169.
[11]
Kwon-Chung KJ, Boekhout T, Fell JW, Diaz M (2002) (1557) Proposal to conserve the name Cryptococcus gattii against C.hondurianus and C.basillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae). Taxon 51: 804–806.
[12]
Litvintseva AP, Thakur R, Vilgalys R, Mitchell TG (2006) Multilocus sequence typing reveals three genetic subpopulations of Cryptococcus neoformans var. grubii (serotype A), including a unique population in Botswana. Genetics 172: 2223–2238.
[13]
Choi YH, Ngamskulrungroj P, Varma A, Sionov E, Hwang SM, et al. (2010) Prevalence of the VNIc genotype of Cryptococcus neoformans in non-HIV-associated cryptococcosis in the Republic of Korea. FEMS Yeast Res 10: 769–778.
[14]
Chen J, Varma A, Diaz MR, Litvintseva AP, Wollenberg KK, et al. (2008) Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China. Emerg Infect Dis 14: 755–762.
[15]
Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, et al. (2004) A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A 101: 17258–17263.
[16]
Fraser JA, Giles SS, Wenink EC, Geunes-Boyer SG, Wright JR, et al. (2005) Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature 437: 1360–1364.
[17]
Byrnes EJ 3rd, Li W, Lewit Y, Ma H, Voelz K, et al. (2010) Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog 6: e1000850.
[18]
MacDougall L, Kidd SE, Galanis E, Mak S, Leslie MJ, et al. (2007) Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerg Infect Dis 13: 42–50.
[19]
Ellis DH, Pfeiffer TJ (1990) Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol 28: 1642–1644.
[20]
Kwon-Chung KJ, Bennett JE (1984) Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 120: 123–130.
[21]
Granados DP, Castaneda E (2006) Influence of climatic conditions on the isolation of members of the Cryptococcus neoformans species complex from trees in Colombia from 1992-2004. FEMS Yeast Res 6: 636–644.
[22]
Bennett JE, Kwon-Chung KJ, Theodore TS (1978) Biochemical differences between serotypes of Cryptococcus neoformans. Sabouraudia 16: 167–174.
[23]
Kwon-Chung KJ, Bennett JE, Theodore TS (1978) Cryptococcus bacillisporus sp. nov.: serotype B–C of Cryptococcus neoformans. International Journal of Systematic Bacteriology 28: 616–620.
[24]
Dufait R, Velho R, De Vroey C (1987) Rapid identification of the two varieties of Cryptococcus neoformans by D-proline assimilation. Mykosen 30: 483.
[25]
Nishikawa MM, Sant'Anna OD, Lazera MS, Wanke B (1996) Use of D-proline assimilation and CGB medium for screening Brazilian Cryptococcus neoformans isolates. J Med Vet Mycol 34: 365–366.
[26]
Salkin IF, Hurd NJ (1982) New medium for differentiation of Cryptococcus neoformans serotype pairs. J Clin Microbiol 15: 169–171.
[27]
Kwon-Chung KJ, Polacheck I, Bennett JE (1982) Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 15: 535–537.
[28]
Magasanik B, Kaiser CA (2002) Nitrogen regulation in Saccharomyces cerevisiae. Gene 290: 1–18.
[29]
Wong KH, Hynes MJ, Davis MA (2008) Recent advances in nitrogen regulation: a comparison between Saccharomyces cerevisiae and filamentous fungi. Eukaryot Cell 7: 917–925.
[30]
Fu YH, Marzluf GA (1987) Characterization of nit-2, the major nitrogen regulatory gene of Neurospora crassa. Mol Cell Biol 7: 1691–1696.
[31]
Mitchell AP, Magasanik B (1984) Regulation of glutamine-repressible gene products by the GLN3 function in Saccharomyces cerevisiae. Mol Cell Biol 4: 2758–2766.
[32]
Limjindaporn T, Khalaf RA, Fonzi WA (2003) Nitrogen metabolism and virulence of Candida albicans require the GATA-type transcriptional activator encoded by GAT1. Mol Microbiol 50: 993–1004.
[33]
Hensel M, Arst HN Jr, Aufauvre-Brown A, Holden DW (1998) The role of the Aspergillus fumigatus areA gene in invasive pulmonary aspergillosis. Mol Gen Genet 258: 553–557.
[34]
Snoeijers SS, Vossen P, Goosen T, Van den Broek HW, De Wit PJ (1999) Transcription of the avirulence gene Avr9 of the fungal tomato pathogen Cladosporium fulvum is regulated by a GATA-type transcription factor in Aspergillus nidulans. Mol Gen Genet 261: 653–659.
[35]
Lee IR, Chow EW, Morrow CA, Djordjevic JT, Fraser JA (2011) Nitrogen metabolite repression of metabolism and virulence in the human fungal pathogen Cryptococcus neoformans. Genetics 188: 309–323.
[36]
Kmetzsch L, Staats CC, Simon E, Fonseca FL, Oliveira DL, et al. (2010) The GATA–type transcriptional activator Gat1 regulates nitrogen uptake and metabolism in the human pathogen Cryptococcus neoformans. Fungal Genet Biol 48: 192–199.
[37]
Casadevall A, Perfect JR (1998) Cryptococcus neoformans. WashingtonDC: ASM press.
[38]
Kwon-Chung KJ (1975) A new genus, filobasidiella, the perfect state of Cryptococcus neoformans. Mycologia 67: 1197–1200.
[39]
Kwon-Chung KJ (1976) A new species of Filobasidiella, the sexual state of Cryptococcus neoformans B and C serotypes. Mycologia 68: 943–946.
[40]
Kwon-Chung KJ, Wickes BL, Stockman L, Roberts GD, Ellis D, et al. (1992) Virulence, serotype, and molecular characteristics of environmental strains of Cryptococcus neoformans var. gattii. Infect Immun 60: 1869–1874.
[41]
Ma H, Hagen F, Stekel DJ, Johnston SA, Sionov E, et al. (2009) The fatal fungal outbreak on Vancouver Island is characterized by enhanced intracellular parasitism driven by mitochondrial regulation. Proc Natl Acad Sci U S A 106: 12980–12985.
[42]
Ngamskulrungroj P, Himmelreich U, Breger JA, Wilson C, Chayakulkeeree M, et al. (2009) The trehalose synthesis pathway is an integral part of the virulence composite for Cryptococcus gattii. Infect Immun 77: 4584–4596.
[43]
Ngamskulrungroj P, Price J, Sorrell T, Perfect JR, Meyer W (2011) Cryptococcus gattii virulence composite: candidate genes revealed by microarray analysis of high and less virulent Vancouver island outbreak strains. PLoS One 6: e16076.
[44]
Narasipura SD, Chaturvedi V, Chaturvedi S (2005) Characterization of Cryptococcus neoformans variety gattii SOD2 reveals distinct roles of the two superoxide dismutases in fungal biology and virulence. Mol Microbiol 55: 1782–1800.
[45]
Ngamskulrungroj P, Serena C, Gilgado F, Malik R, Meyer W (2011) Global VGIIa isolates are of comparable virulence to the major fatal Cryptococcus gattii Vancouver Island outbreak genotype. Clin Microbiol Infect 17: 251–258.
[46]
Perfect JR, Ketabchi N, Cox GM, Ingram CW, Beiser CL (1993) Karyotyping of Cryptococcus neoformans as an epidemiological tool. J Clin Microbiol 31: 3305–3309.
[47]
Polacheck I, Kwon-Chung KJ (1980) Creatinine metabolism in Cryptococcus neoformans and Cryptococcus bacillisporus. J Bacteriol 142: 15–20.
[48]
Piper MD, Hong SP, Eissing T, Sealey P, Dawes IW (2002) Regulation of the yeast glycine cleavage genes is responsive to the availability of multiple nutrients. FEMS Yeast Res 2: 59–71.
[49]
McNeil JB, Zhang F, Taylor BV, Sinclair DA, Pearlman RE, et al. (1997) Cloning, and molecular characterization of the GCV1 gene encoding the glycine cleavage T-protein from Saccharomyces cerevisiae. Gene 186: 13–20.
[50]
Sinclair DA, Hong SP, Dawes IW (1996) Specific induction by glycine of the gene for the P-subunit of glycine decarboxylase from Saccharomyces cerevisiae. Mol Microbiol 19: 611–623.
[51]
Nagarajan L, Storms RK (1997) Molecular characterization of GCV3, the Saccharomyces cerevisiae gene coding for the glycine cleavage system hydrogen carrier protein. J Biol Chem 272: 4444–4450.
[52]
Ross J, Reid GA, Dawes IW (1988) The nucleotide sequence of the LPD1 gene encoding lipoamide dehydrogenase in Saccharomyces cerevisiae: comparison between eukaryotic and prokaryotic sequences for related enzymes and identification of potential upstream control sites. J Gen Microbiol 134: 1131–1139.
[53]
Williamson PR (1994) Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase. J Bacteriol 176: 656–664.
[54]
Williamson PR (1997) Laccase and melanin in the pathogenesis of Cryptococcus neoformans. Front Biosci 2: e99–107.
[55]
Gerik KJ, Donlin MJ, Soto CE, Banks AM, Banks IR, et al. (2005) Cell wall integrity is dependent on the PKC1 signal transduction pathway in Cryptococcus neoformans. Mol Microbiol 58: 393–408.
[56]
Kurtzman CP, Fell J, Boekhout T (2011) The yeasts: A taxonomic study. Amsterdam: Elsevier.
[57]
Segal E, Ajello L (1976) Evaluation of a new system for the rapid identification of clinically important yeasts. J Clin Microbiol 4: 157–159.
[58]
Philpot CM (1977) The use of nutritional tests for the differentiation of dermatophytes. Sabouraudia 15: 141–150.
[59]
Klein KR, Hall L, Deml SM, Rysavy JM, Wohlfiel SL, et al. (2009) Identification of Cryptococcus gattii by use of L-canavanine glycine bromothymol blue medium and DNA sequencing. J Clin Microbiol 47: 3669–3672.
[60]
Leal AL, Faganello J, Bassanesi MC, Vainstein MH (2008) Cryptococcus species identification by multiplex PCR. Med Mycol 46: 377–383.
[61]
McTaggart L, Richardson SE, Seah C, Hoang L, Fothergill A, et al. (2011) Rapid identification of Cryptococcus neoformans var. grubii, C. neoformans var. neoformans, and C. gattii by use of rapid biochemical tests, differential media, and DNA sequencing. J Clin Microbiol 49: 2522–2527.
[62]
Monschau N, Stahmann KP, Sahm H, McNeil JB, Bognar AL (1997) Identification of Saccharomyces cerevisiae GLY1 as a threonine aldolase: a key enzyme in glycine biosynthesis. FEMS Microbiol Lett 150: 55–60.
[63]
Kastanos EK, Woldman YY, Appling DR (1997) Role of mitochondrial and cytoplasmic serine hydroxymethyltransferase isozymes in de novo purine synthesis in Saccharomyces cerevisiae. Biochemistry 36: 14956–14964.
[64]
McNeil JB, Flynn J, Tsao N, Monschau N, Stahmann K, et al. (2000) Glycine metabolism in Candida albicans: characterization of the serine hydroxymethyltransferase (SHM1, SHM2) and threonine aldolase (GLY1) genes. Yeast 16: 167–175.
[65]
Casadevall A, Steenbergen JN, Nosanchuk JD (2003) ‘Ready made’ virulence and ‘dual use’ virulence factors in pathogenic environmental fungi–the Cryptococcus neoformans paradigm. Curr Opin Microbiol 6: 332–337.
[66]
McClelland CM, Chang YC, Kwon-Chung KJ (2005) High frequency transformation of Cryptococcus neoformans and Cryptococcus gattii by Agrobacterium tumefaciens. Fungal Genet Biol 42: 904–913.
[67]
Davidson RC, Blankenship JR, Kraus PR, de Jesus Berrios M, Hull CM, et al. (2002) A PCR-based strategy to generate integrative targeting alleles with large regions of homology. Microbiology 148: 2607–2615.
[68]
Toffaletti DL, Rude TH, Johnston SA, Durack DT, Perfect JR (1993) Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J Bacteriol 175: 1405–1411.
[69]
Pukkila-Worley R, Gerrald QD, Kraus PR, Boily MJ, Davis MJ, et al. (2005) Transcriptional network of multiple capsule and melanin genes governed by the Cryptococcus neoformans cyclic AMP cascade. Eukaryot Cell 4: 190–201.
[70]
Zaragoza O, Fries BC, Casadevall A (2003) Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO2. Infect Immun 71: 6155–6164.
[71]
Sugui JA, Vinh DC, Nardone G, Shea YR, Chang YC, et al. (2010) Neosartorya udagawae (Aspergillus udagawae), an emerging agent of aspergillosis: how different is it from Aspergillus fumigatus? J Clin Microbiol 48: 220–228.
[72]
Rao GV, Tinkle S, Weissman DN, Antonini JM, Kashon ML, et al. (2003) Efficacy of a technique for exposing the mouse lung to particles aspirated from the pharynx. J Toxicol Environ Health A 66: 1441–1452.
